highly significantp < 0.01
Male Scn1a +/− mice injected with AAV-NaVβ1 experienced a highly significant reduction in spontaneous seizures compared with male Scn1a +/− mice injected with AAV-EV ( Fig. 4B ; t = 3.43, p < 0.01).
Male Scn1a +/− mice injected with AAV-NaVβ1 experienced a highly significant reduction in spontaneous seizures compared with male Scn1a +/− mice injected with AAV-EV ( Fig. 4B ; t = 3.43, p < 0.01).